Moreover, TMPRSS2-ERG fusion can serve as cancer-specific biomarker for early diagnosis of PCa and can be detected in urine samples via reverse transcription–polymerase chain reaction (RT-PCR) or a clinical-grade transcription-mediated amplification (TMA) assay [162,163,164,165,166,167]. Here, TMPRSS2 is linked to cancer.